Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Asian Pac J Allergy Immunol ; 24(2-3): 97-103, 2006.
Article in English | MEDLINE | ID: mdl-17136873

ABSTRACT

The purpose of this study was to compare the safety and efficacy of cetirizine plus pseudoephedrine (C+P) with loratadine plus pseudoephedrine (L+P) in the treatment of perennial allergic rhinitis. This was a double blind, randomized, parallel trial with an active control. Subjects aged 12 to 70 years with perennial allergic rhinitis for at least 2 years were enrolled and randomized to receive either of the active study medications plus a placebo resembling the other, twice daily for 4 weeks. Nasal total symptom scale (NTSS) including sneezing, rhinorrhea, nasal itching and nasal stuffiness is evaluated by subjects daily and at baseline, 2 weeks, and 4 weeks by the investigator as efficacy measurement. A total of 51 eligible patients were enrolled and 45 patients completed the treatment course. Both groups had significant reductions in NTSS after 4 weeks of treatment as assessed by the subjects, but there was no significant difference between the two groups (mean +/- SD) reduction of 4.25 +/- 2.45 with C+P vs. 3.52 +/- 2.41 with L+P, p = 0.215. As assessed by the investigator, sneezing was significantly better at 2 weeks (-1.13 vs. -0.52, p = 0.028) and nasal congestion at 4 weeks (-1.71 vs. -1.19, p = 0.031) in subjects treated with C+P compared to those treated with L+P. There were 37 treatment-related adverse events (5 in 4 subjects in the C+P group and 32 in 16 subjects in the L+P group). It was concluded that both cetirizine plus pseudoephedrine and loratadine plus pseudoephedrine are efficacious for perennial allergic rhinitis in Taiwanese subjects. Relief of sneezing and nasal congestion may be marginally better with the cetirizine preparation, which also seemed to be slightly better tolerated, although the incidence of side effects did not differ significantly.


Subject(s)
Cetirizine/administration & dosage , Ephedrine/administration & dosage , Loratadine/administration & dosage , Rhinitis, Allergic, Perennial/drug therapy , Adolescent , Adult , Aged , Cetirizine/toxicity , Child , Double-Blind Method , Drug Therapy, Combination , Ephedrine/toxicity , Female , Humans , Loratadine/toxicity , Male , Middle Aged , Rhinitis, Allergic, Perennial/complications , Sneezing/drug effects , Taiwan , Treatment Outcome
2.
Asian Pac J Allergy Immunol ; 24(2-3): 167-70, 2006.
Article in English | MEDLINE | ID: mdl-17136883

ABSTRACT

IgE-mediated hypersensitivity to buckwheat is common in Korea, Japan, and some other Asian countries. However, buckwheat is not a common allergen in Taiwan. We report a woman with asthma who had anaphylactic shock, generalized urticaria, and an acute exacerbation of asthma five minutes after ingesting buckwheat. The patient underwent skin prick and Pharmacia CAP testing (Uppsala, Sweden) for specific IgE to buckwheat, white sesame and soybean as well as other common allergens in Taiwan including Dermatophagoides pteronyssinus (Dp), D. farinae (Df), cat and dog dander, cockroach, egg white, cow milk and codfish. The patient had a strongly positive skin prick test response to buckwheat and positive reactions to Dp and latex. Specific IgE results were class 6 for buckwheat, class 4 for Dp and Df, and class 2 for dog dander, wheat, sesame and soybean. Results of an open food challenge with white sesame and soybean were negative. Although buckwheat is a rare allergen in Taiwan, it can cause extremely serious reactions and should be considered in patients presenting with anaphylaxis after exposure to buckwheat.


Subject(s)
Allergens/immunology , Anaphylaxis/immunology , Fagopyrum/immunology , Adult , Anaphylaxis/diagnosis , Anaphylaxis/etiology , Asthma/etiology , Asthma/immunology , Edible Grain/immunology , Female , Humans , Hypersensitivity, Immediate , Skin Tests , Taiwan , Urticaria/etiology , Urticaria/immunology
3.
Acta Paediatr Taiwan ; 47(6): 297-302, 2006.
Article in English | MEDLINE | ID: mdl-17407981

ABSTRACT

BACKGROUND: Juvenile recurrent parotitis (JRP) is a rare, recurrent non-obstructive, nonsuppurative parotid inflammation in young children with a multifactorial etiology. METHODS: The records of 12 children with recurrent parotitis were retrospectively reviewed. RESULTS: The age of onset ranged from 3 to 8 years (mean, 5.1 years). Each attack lasted an average of 3.5 days. The major clinical manifestations included fever (75%), swelling (100%), and pain (100%). One girl also had xerostomia and keratoconjunctivitis sicca. Her biopsy specimen from a minor salivary gland was consistent with juvenile Sjiigren's syndrome. Six patients had positive antinuclear antibodies (4 with a speckled pattern and 2 each with a homogeneous or nucleolar pattern). Bilateral sialography was performed in 9 children. The results in 4 were normal, 2 had unilateral punctate sialectasis, and 3 had bilateral sialectasis. After sialography, the frequency of recurrences significantly decreased from 5.11 to 0.56 per year (P < 0.05). CONCLUSIONS: Bilateral sialography is useful for the diagnosis of JRP, but it also appears to decrease the frequency of recurrences.


Subject(s)
Parotitis/diagnosis , Adolescent , Antibodies, Antinuclear/blood , Child , Child, Preschool , Female , Humans , Male , Parotitis/etiology , Parotitis/therapy , Recurrence , Retrospective Studies , Sialography
SELECTION OF CITATIONS
SEARCH DETAIL
...